Simon John Sturge's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 171,000 Class A ordinary shares, par value $0.0001 per share done at an average price of $53.7 . Disclosure was reported to the exchange on Oct. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MoonLake Immunotherapeutic... | Simon John Sturge | Director | Sale of securities on an exchange or to another person at price $ 53.72 per share. | 04 Oct 2024 | 171,000 | 171,980 | - | 53.7 | 9,186,120 | Class A ordinary shares, par value $0.0001 per share |
MoonLake Immunotherapeutic... | Simon John Sturge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,688 | 7,688 | - | - | Option to Buy | |
MoonLake Immunotherapeutic... | Simon John Sturge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 11,297 | 11,297 | - | - | Option to Buy | |
MoonLake Immunotherapeutic... | Simon John Sturge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 45,000 | 45,000 | - | - | Option to Buy |